Open mobile menu
Model.SiteSettings!.GetInTouchLink!.Name Contact Us
Jroberts Jruaux Dpingstone 03 B012378 CROPPED
Insights

News

Stay up to date with news about Secerna and intellectual property topics.

REXULTI

A to Z: Drugs in Highlight: R is for REXULTI®

News A to Z Feature 03/04/2025

This series continues to explore the fascinating world of pharmaceuticals. Next up is R is for REXULTI® (from Otsuka Pharmaceutical), also sold under the brand name RXULTI®, It is an antipsychotic medicine used to treat schizophrenia in adults. It is also used as an adjunctive therapy for the treatment of major depressive disorder.

Read more
IPO Image Istock (1)
Industry news, News 25/08/2023

Changes to UK IPO's Representation Requirements for Trade Marks and Designs

2
News, Team news 23/08/2023

Secerna's 2023 intern: Kimberly Munemo in profile

GMO
European, News 21/08/2023

EU plans to relax grip on genetically modified organisms regulations

Secerna Website Images 2023 (3)
Industry news, News 16/08/2023

Oppenheimer: Quantum technology, patents and the silver screen

Secerna Website Images 2023 (1)
Events, News 10/08/2023

Secerna to attend Intellectual Property Owners Association 2023 Annual Meeting

B012632
Team news, Careers 07/08/2023

Jay Ruaux in profile

Seeking Clarity
European, News 07/08/2023

Seeking Clarity: The Controversy Surrounding Article 84 EPC and Description Adaption

Farm to Fork Patents IP
European, News 02/08/2023

Farm to fork: Innovating to create a sustainable food system

EPO
European, News 01/08/2023

Abolition of the European Patent Office’s ten-day rule draws closer

12 13 14 15 16 17 18 19 20 21 22